Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: A meta-analytic review

Journal of Clinical Psychiatry

Volumn 74, Issue 6, 2013, Pages 595-602

  McHugh, R Kathryn ^a,b   Whitton, Sarah W ^c   Peckham, Andrew D ^d   Welge, Jeffrey A ^e   Otto, Michael W ^f  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANXIETY DISORDER; DEPRESSION; EVIDENCE BASED PRACTICE; HEALTH CARE UTILIZATION; HELP SEEKING BEHAVIOR; HUMAN; MENTAL DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PATIENT SELECTION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

EID: 84879598958     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12r07757     Document Type: Review

References (68)

1. American Psychological Association. APA Presidential Task Force on Evidence-Based Practice. Washington, DC: American Psychological Association; 2006.
2. American Psychiatric Association. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorder Compendium. Arlington, VA: American Psychiatric Publishing; 2006.
3. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000;283(19):2529-2536. PubMed
4. Butler AC, Chapman JE, Forman EM, et al. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31. doi:10.1016/j.cpr.205.07.03 PubMed
5. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006;74(4):658-670. doi:10.1037/02-06X.74.4.658 PubMed
6. Roshanaei-Moghaddam B, Pauly MC, Atkins DC, et al. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety? Depress Anxiety. 2011;28(7):560-567. doi:10.102/da.20829 PubMed
7. Mergl R, Henkel V, Allgaier AK, et al. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? results from a randomized controlled trial including a patients' choice arm. Psychother Psychosom. 2011;80(1):39-47. doi:10.159/031872 PubMed
8. Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ. 2008;337:a1864. PubMed
9. Swift JK, Callahan JL, Vollmer BM. Preferences. J Clin Psychol. 2011;67(2):155-165. doi:10.102/jclp.20759 PubMed
10. Dwight-Johnson M, Lagomasino IT, Hay J, et al. Effectiveness of collaborative care in addressing depression treatment preferences among low-income Latinos. Psychiatr Serv. 2010;61(11):1112-1118. doi:10.176/api.ps.61. 1.12 PubMed
11. Mojtabai R, Olfson M, Sampson NA, et al. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011;41(8):1751-1761. doi:10.1017/S03291710291 PubMed
12. Stroup DF, Berlin JA, Morton SC, et al; for the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008-2012. PubMed
13. Chandra A, Scott MM, Jaycox LH, et al. Racial/ethnic differences in teen and parent perspectives toward depression treatment. J Adolesc Health. 2009;44(6):546-553. doi:10.1016/j.jadohealth.208.10.137 PubMed
14. Lau J, Ioannidis JP, Terrin N, et al. The case of the misleading funnel plot. BMJ. 2006;333(7568):597-600. doi:10.136/bmj.3.7568.597 PubMed
15. Driessen E, Cuijpers P, Hollon SD, et al. Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? a meta-analysis. J Consult Clin Psychol. 2010;78(5):668-680. doi:10.1037/a020570 PubMed
16. Eddy KT, Dutra L, Bradley R, et al. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev. 2004;24(8):1011-1030. doi:10.1016/j.cpr.204.08.04 PubMed
17. Goncalves DC, Byrne GJ. Interventions for generalized anxiety disorder in older adults: systematic review and meta-analysis. J Anxiety Disord. 2012;26(1):1-11. doi:10.1016/j.janxdis.201.08.010 PubMed
18. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005;88(1):27-45. doi:10.1016/j.jad.205.05.03 PubMed
19. Spielmans GI, Berman MI, Usitalo AN. Psychotherapy versus secondgeneration antidepressants in the treatment of depression: a meta-analysis. J Nerv Ment Dis. 2011;199(3):142-149. doi:10.1097/NMD. 0b013e31820caefb PubMed
20. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 Summary. Advance Data From Vital and Health Statistics. No. 387. Hyattsville, MD: National Center for Health Statistics; 2007.
21. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848-856. doi:10.101/ archgenpsychiatry.209.81 PubMed
22. Byford S, Barrett B, Roberts C, et al. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. Br J Psychiatry. 2007;191(6):521-527. doi:10.192/bjp.bp.107.038984 PubMed
23. Heuzenroeder L, Donnelly M, Haby MM, et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust N Z J Psychiatry. 2004;38(8):602-612. doi:10.1080/j.140-1614.204.01423.x PubMed
24. McHugh RK, Otto MW, Barlow DH, et al. Cost-efficacy of individual and combined treatments for panic disorder. J Clin Psychiatry. 2007;68(7):1038-1044. doi:10.408/JCP.v68n0710 PubMed
25. Beland SG, Tournier M, Galbaud du Fort G, et al. Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approach. Value Health. 2011;14(4):492-498. doi:10.1016/j.jval.2010.1.015 PubMed
26. Goethe JW, Woolley SB, Cardoni AA, et al. Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence. J Clin Psychopharmacol. 2007;27(5):451-458. doi:10.1097/jcp.0b013e31815152a5 PubMed
27. Bambauer KZ, Soumerai SB, Adams AS, et al. Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty. J Clin Psychiatry. 2007;68(6):867-873. PubMed
28. McHugh RK, Barlow DH. The dissemination and implementation of evidence-based psychological treatments: a review of current efforts. Am Psychol. 2010;65(2):73-84. doi:10.1037/a018121 PubMed
29. Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011;6(1):21-37. doi:10.17/1745691610393527
30. Fernandez y Garcia E, Franks P, Jerant A, et al. Depression treatment preferences of Hispanic individuals: exploring the influence of ethnicity, language, and explanatory models. J Am Board Fam Med. 2011;24(1):39-50. doi:10.312/jabfm.201.01.1018 PubMed
31. Kocsis JH, Leon AC, Markowitz JC, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry. 2009;70(3):354-361. doi:10.408/JCP.08m04371 PubMed
32. Backenstrass M, Joest K, Frank A, et al. Preferences for treatment in primary care: a comparison of nondepressive, subsyndromal and major depressive patients. Gen Hosp Psychiatry. 2006;28(2):178-180. doi:10.1016/j.genhospsych. 205.10.01 PubMed
33. Hodges L, Butcher I, Kleiboer A, et al. Patient and general practitioner preferences for the treatment of depression in patients with cancer: how, who, and where? J Psychosom Res. 2009;67(5):399-402. doi:10.1016/j.jpsychores.209.03. 08 PubMed
34. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342(20):1462-1470. PubMed
35. Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010;304(8):875-880. doi:10.101/jama.2010.192 PubMed
36. Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin Psychol Sci Pract. 2005;12(1):72-86. doi:10.1093/clipsy.bpi09
37. Otto MW, McHugh RK, Kantak KM. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: medication effects, glucocorticoids, and attenuated outcomes. Clin Psychol Sci Pract. 2010;17(2):91-103. doi:10.1/j.1468-2850.2010.0198.x
38. Alegria M, Chatterji P, Wells K, et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv. 2008;59(11):1264-1272. doi:10.176/api.ps.59.1.1264 PubMed
39. Davis RG, Ressler KJ, Schwartz AC, et al. Treatment barriers for low-income, urban African Americans with undiagnosed posttraumatic stress disorder. J Trauma Stress. 2008;21(2):218-222. doi:10.102/jts.20313 PubMed
40. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003;41(4):479-489. doi:10.1097/01.MLR.05328.58042.E4 PubMed
41. Givens JL, Houston TK, Van Voorhees BW, et al. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29(3):182-191. doi:10.1016/j.genhospsych.206.1.02 PubMed
42. Angelo FN, Miller HE, Zoellner LA, et al. "I need to talk about it": a qualitative analysis of trauma-exposed women's reasons for treatment choice. Behav Ther. 2008;39(1):13-21. doi:10.1016/j.beth.207.02.02 PubMed
43. Becker CB, Meyer G, Price JS, et al. Law enforcement preferences for PTSD treatment and crisis management alternatives. Behav Res Ther. 2009;47(3):245-253. doi:10.1016/j.brat.209.01.01 PubMed
44. Becker CB, Darius E, Schaumberg K. An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder. Behav Res Ther. 2007;45(12):2861-2873. doi:10.1016/j.brat.207.05.06 PubMed
45. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry. 2001;58(7):631-640. doi:10.101/archpsyc.58.7.631 PubMed
46. Chilvers C, Dewey M, Fielding K, et al; Counselling versus Antidepressants in Primary Care Study Group. Antidepressant drugs and generic counseling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ. 2001;322(7289):772-775. PubMed
47. Churchill R, Khaira M, Gretton V, et al; Nottingham Counselling and Antidepressants in Primary Care (CAPC) Study Group. Treating depression in general practice: factors affecting patients' treatment preferences. Br J Gen Pract. 2000;50(460):905-906. PubMed
48. Davidson KW, Rieckmann N, Clemow L, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med. 2010;170(7):600-608. PubMed
49. Deacon BJ, Abramowitz JS. Patients' perceptions of pharmacological and cognitive-behavioral treatments for anxitey disorders. Behav Ther. 2005;36(2):139-145. doi:10.1016/S05-7894(05)8062-0
50. Dobscha SK, Corson K, Gerrity MS. Depression treatment preferences of VA primary care patients. Psychosomatics. 2007;48(6):482-488. doi:10.176/api.psy. 48.6.482 PubMed
51. Dwight-Johnson M, Sherbourne CD, Liao D, et al. Treatment preferences among depressed primary care patients. J Gen Intern Med. 2000;15(8): 527-534. doi:10.1046/j.1525-1497.20.08035.x PubMed
52. Fann JR, Jones AL, Dikmen SS, et al. Depression treatment preferences after traumatic brain injury. J Head Trauma Rehabil. 2009;24(4):272-278. doi:10.1097/HTR.0b013e3181a6342 PubMed
53. Feeny NC, Zoellner LA, Mavissakalian MR, et al. What would you choose? sertraline or prolonged exposure in community and PTSD treatment seeking women. Depress Anxiety. 2009;26(8):724-731. doi:10.102/da.2058 PubMed
54. Feeny NC, Zoellner LA, Kahana SY. Providing a treatment rationale for PTSD: does what we say matter? Behav Res Ther. 2009;47(9):752-760. doi:10.1016/j.brat.209.06.07 PubMed
55. Goodman JH. Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth. 2009;36(1):60-69. doi:10.1/j.1523-536X.208.0296.x PubMed
56. Iacoviello BM, McCarthy KS, Barrett MS, et al. Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials. J Consult Clin Psychol. 2007;75(1):194-198. doi:10.1037/02-06X.75.1.194 PubMed
57. Jaycox LH, Asarnow JR, Sherbourne CD, et al. Adolescent primary care patients' preferences for depression treatment. Adm Policy Ment Health. 2006;33(2):198-207. doi:10.107/s1048-06-03-7 PubMed
58. Kwan BM, Dimidjian S, Rizvi SL. Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther. 2010;48(8):799-804. doi:10.1016/j.brat.2010.04.03 PubMed
59. Leykin Y, Derubeis RJ, Gallop R, et al. The relation of patients' treatment preferences to outcome in a randomized clinical trial. Behav Ther. 2007;38(3):209-217. doi:10.1016/j.beth.206.08.02 PubMed
60. Lin P, Campbell DG, Chaney EF, et al. The influence of patient preference on depression treatment in primary care. Ann Behav Med. 2005;30(2): 164-173. doi:10.1207/s15324796abm3029 PubMed
61. Ogrodniczuk JS, Piper WE, Joyce AS, et al. Alexithymia and treatment preferences among psychiatric outpatients. Psychother Psychosom. 2009;78(6):383-384. doi:10.159/0235981 PubMed
62. Patel SR, Simpson HB. Patient preferences for obsessive-compulsive disorder treatment. J Clin Psychiatry. 2010;71(11):1434-1439. doi:10.408/JCP.09m0537blu PubMed
63. Raue PJ, Schulberg HC, Heo M, et al. Patients' depression treatment preferences and initiation, adherence, and outcome: a randomized primary care study. Psychiatr Serv. 2009;60(3):337-343. doi:10.176/api.ps.60.3.37 PubMed
64. Unutzer J, Katon W, Callahan CM, et al. Depression treatment in a sample of 1,801 depressed older adults in primary care. J Am Geriatr Soc. 2003;51(4):505-514. doi:10.1046/j.1532-5415.203.5159.x PubMed
65. Van HL, Dekker J, Koelen J, et al. Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression. Psychother Res. 2009;19(2):205-212. doi:10.1080/105030802702097 PubMed
66. Walker J, Vincent N, Furer P, et al. Treatment preference in hypochondriasis. J Behav Ther Exp Psychiatry. 1999;30(4):251-258. doi:10.1016/S05-7916(9)027-0 PubMed
67. Zafar AM, Jawaid A, Ashraf H, et al. Psychotherapy as a treatment modality for psychiatric disorders: perceptions of general public of Karachi, Pakistan. BMC Psychiatry. 2009;9:37. PubMed
68. Zoellner LA, Feeny NC, Cochran B, et al. Treatment choice for PTSD. Behav Res Ther. 2003;41(8):879-886. doi:10.1016/S05-7967(02)010-6 PubMed